AlphAIalphai — Financial news for AI agents
Stock TitanAPR 163 min read$OPRA

Opera schedules April 28 earnings release and 8 a.m. ET call

Opera (NASDAQ: OPRA) will release its first quarter 2026 financial results before market open on April 28, 2026. Management will host a conference call and live webcast on the same day at 8:00 a.m. ET to discuss the results. The earnings release and webcast will be available on investor.opera.com, with dial-in numbers and a confirmation code provided for listeners.

Original reporting
Stock Titan
Published Apr 16, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 16, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Opera schedules April 28 earnings release and 8 a.m. ET call — source image
Source · Stock Titan
Decision brief

The 30-second read

$OPRANeutralMed
01

Why it matters

Earnings results are expected to influence short-term trading strategies; longer-term investors should focus on fundamental growth prospects.

02

Market read

While Opera's earnings are significant for short-term traders, the overall market impact remains moderate due to its market capitalization.

03

What to watch

Market-wide macroeconomic uncertainties could overshadow company-specific earnings impact.

Timing: High, as the earnings release is scheduled for April 28, 2026.

Background

Opera is a NASDAQ-listed company specializing in digital content and advertising services.

Company-level read

Ticker impact

$OPRANeutralMedium confidence
Context

High relevance due to upcoming earnings release.

Expected impact

Potential short-term increase in stock price if earnings surpass expectations; risk of decline if results are below forecasts.

Evidence & confidence

Earnings reports typically influence stock prices; however, the actual impact depends on the results relative to market expectations.

Market effects

Sector

Positive sentiment in the technology and financial markets sectors due to earnings season.

Regional

Potentially positive impact on regional markets with high trading volumes in tech stocks.

Global

Moderate, as Opera's market cap and global presence are limited.

Counterpoint

What could challenge this read

Earnings may fall short of expectations, leading to a sharp decline in stock price.

Key entities

  • Company
    Opera

    A digital content and advertising company listed on NASDAQ.

Read at source← All news

Related articles

AUG 25
$OPRAHigh

Opera (OPRA) Moved Its Earnings Forward. Can AI Browser Growth Produce Another Guidance Increase?

Opera Limited (OPRA) moved its Q2 earnings release to August 19. Q1 revenue rose 23% to $175.8M, adjusted EBITDA up 30% to $42.0M, both exceeding guidance. The company saw strong user growth in Western markets, with AI features driving engagement. Opera raised its full-year outlook, projecting revenue of $727M-$740M and adjusted EBITDA of $170M-$174M. The company's revenue model remains concentrated in advertising and search queries.

yahoo.com2 min
AUG 21
$OPRAHigh

Opera Shares Drop Despite Revenue Beat and Stronger 2026 Outlook

Opera Limited (OPRA) reported Q2 earnings with revenue of $178.1M, beating estimates, and raised its 2026 outlook. However, shares fell 5.48% after adjusted EPS of $0.26 missed expectations by $0.01. Adjusted EBITDA grew 32% to $42.4M, and Q3 revenue guidance was set at $181M-$183M, above consensus.

yahoo.com2 min
AUG 20
$OPRAHighAI 9/10

Opera (OPRA) Q2 2026 Earnings Call Transcript

Opera (OPRA) reported Q2 2026 revenue of $178.1M, up 25% YoY, driven by advertising and query growth. Adjusted EBITDA rose 32% to $42.4M. MAUs reached 288M, with Western market users growing 4%. Full-year revenue guidance was raised to $734M-$742M. Management highlighted AI integration and high-ARPU Western markets as growth drivers. The company returned $35.6M to shareholders via dividends and repurchased $11.1M of shares.

fool.com2 min
AUG 19
$OPRAHighAI 8/10

Opera Reports Second Quarter 2026 Results Beyond the High End of Guidance Ranges

Opera Limited (OPRA) reported Q2 2026 revenue of $178.1M, up 25% YoY, and adjusted EBITDA of $42.4M, up 32% YoY, exceeding guidance. Q3 revenue guidance is $181-183M with a 23% adjusted EBITDA margin. Full-year guidance raised to $734-742M revenue and $172-175M adjusted EBITDA. Advertising and query revenue grew 27% and 21% YoY, respectively. MAUs reached 288M, with ARPU up 25% to $2.46. Opera paid a $0.40 dividend and repurchased 0.64M shares.

prnewswire.com2 min
AUG 19
$OPRAHigh

Opera Ltd (OPRA): Financial results for Q2 2026

Opera Ltd (OPRA) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Opera Reports Second Quarter 2026 Results Beyond the High End of Guidance Ranges Revenue increased 25% year-over-year to $178.1 million, exceeding the guidance range Adjusted EBITDA was $42.4 million, representing a 24% margin and 32% year-over-year growth, also exce

SEC EDGAR 6-K2 min
SEP 8
$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min